HOME >> BIOLOGY >> NEWS
Pair of microRNA molecules controls major oncogene in most common leukemia

PHILADELPHIA -- Researchers at Ohio State University have discovered that two microRNA (miRNA) molecules help control the oncogene responsible for a dangerous form of B-cell chronic lymphocytic leukemia (B-CLL), the most common human leukemia in the world.

Their findings, published in the December 15 issue of Cancer Research, demonstrate that miRNAs are emerging as powerful regulators of gene expression in cancer development, and could offer new targets for drug treatment, the investigators say.

In this case, high levels of two miRNAs known as miR-29 and miR-181 seem to suppress expression of the TCL1 oncogene that drives the most aggressive forms of the leukemia, said the studys lead author, Yuri Pekarsky, Ph.D., assistant professor in the Department of Molecular Virology, Immunology and Medical Genetics at Ohio State Universitys Comprehensive Cancer Center.

"We have found a direct inverse association between expression of miR-29 and miR-181 and that of the TCL1 oncogene," he said. "It works in both directions. High expression of these miRNAs correlates with low expression of TCL1, in the indolent form of cancer that is less likely to progress. A low level of miR-29 and miR-181 is associated with a much more aggressive cancer."

Drugs that boost production of these two natural TCL1 inhibitors might work as a future treatment for B-cell chronic lymphocytic leukemia, he said. These molecules could also be combined with 12 other miRNAs known to be associated with B-CLL to provide a test that may help determine prognosis and treatment, he said.

Researchers at Ohio State have been leaders in characterizing the role of miRNAs in cancer development. These small molecules are single-stranded RNA molecules that can act either as tumor suppressors or oncogenes. They can block transcription of genes by stopping them from producing messenger RNA or can inhibit translation of the genes by blocking production of proteins f
'"/>

Contact: Staci Vernick Goldberg
goldberg@aacr.org
215-440-9300
American Association for Cancer Research
15-Dec-2006


Page: 1 2

Related biology news :

1. Penn researchers discover how microRNAs control protein synthesis
2. Mechanism of microRNAs deciphered
3. Unicellular microRNA discovery
4. Xie Lab demonstrates the role of microRNA pathway
5. microRNA function in neurogenesis
6. Penn researchers find role for microRNAs in angiogenesis
7. Activation of microRNA inhibits cancer gene in human cancer cells
8. Single microRNA causes cancer in transgenic mouse
9. microRNA-mediated metabolism
10. Role of microRNA identified in thyroid cancer
11. Twin molecular scissors link creation of microRNAs with gene-silencing

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2020)... , ... August 20, 2020 , ... ... Hassan Movahhed , a Clinical Operations executive with expertise in clinical trial ... joined the firm as an Expert Consultant. Throughout his career, Mr. Movahhed has ...
(Date:8/12/2020)... ... August 12, 2020 , ... Mosio recently announced its newly ... health agencies of all sizes. With a focus on tracking symptoms and monitoring ... health care, Mosio helps public health departments automate communications and provide more personalized ...
(Date:8/7/2020)... ... August 06, 2020 , ... ... in the prestigious National STEM Scholar Program, a unique professional development program that ... project support for middle school science teachers nationwide. , Created in partnership between ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is now ... With 50 million stem cells total, patients may choose which extremities they would like ... arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is obtained ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, ... have entered into a strategic partnership whereby Catalent will provide support for the ...
(Date:7/31/2020)... ... July 29, 2020 , ... The ... radiation centers in 16 countries, has reached its 20th anniversary of worldwide use. ... routine use at top universities including University of Pennsylvania, University of Michigan, University ...
Breaking Biology Technology:
Cached News: